// App-Quantinova.ai

1148 : GWAS Identified New Genes in Synovial Fibroblasts Linked to Early Remission in RA

Researchers

Presenter

  • Marc Maurits

Principal Investigators

  • Erik van den Akker

  • Johan Askling

  • Anne Barton

  • Stephan Blüml

  • Stephan Böhringer

  • Andrew Cope

  • Paul Emery

  • Stephen Eyre

  • Priya Gaddi

  • Isidoro Gonzalez

  • Carl Goodyear

  • Annette van der Helm-van Mil

  • Xinli Hu

  • Tom Huizinga

  • John D Isaacs

  • Scott Jelinsky

  • Martina Johannesson

  • Samantha Jurado Zapata

  • Changlin Ke

  • Lars Klareskog

  • Dennis Lendrem

  • Myles Lewis

  • Mingdong Liu

  • Paul Martin

  • Iain B McInnes

  • Raphael Micheroli

  • Ann Morgan

  • Fraser Morton

  • Najib Naamane

  • Gisela Orozco

  • Caroline Ospelt

  • Leonid Padyukov

  • Caron Paterson

  • Darren Plant

  • Duncan Porter

  • Arthur Pratt

  • Soumya Raychaudhuri

  • Louise Reynard

  • Luis Rodriguez-Rodriguez

  • Daniela Sieghart

  • Paul Studenic

  • John Taylor

  • René Toes

  • Marloes Verstappen

  • Suzanne Verstappen

  • Helga Westerlind

  • Aaron Winkler

  • Rachel Knevel

Medical Centers

  • Institute of Infection, Immunity and Inflammation, College of Medicine, Veterinary Medicine and Life Sciences, University of Glasgow, Glasgow, United Kingdom

  • Leiden University Medical Centre, Leiden, Netherlands

  • University of Leeds, Leeds, United Kingdom

  • Medical University of Vienna, Vienna, Austria

  • LUMC, Leiden, Netherlands

  • Gartnavel General Hospital, Glasgow, United Kingdom

  • Institute for Translational and Clinical Research, Newcastle University and Musculoskeletal Unit, Newcastle upon Tyne Hospitals, Newcastle, United Kingdom

  • Newcastle University, Newcastle upon Tyne, United Kingdom

  • Newcastle University, Newcastle upon Tyne, United Kingdom

  • University Hospital Zurich, Department of Neuropathology, Zurich, Switzerland

  • Hospital Clinico San Carlos, IBD Unit, Madrid, Spain

  • Instituto de Investigación Sanitaria San Carlos, Rheumatology, Madrid, Spain

  • University of Leeds, Euclid, OH

  • Leiden University Medical Center and Zuyderland Medical Centre, Leiden, Netherlands

  • Queen Mary University of London, London, United Kingdom

  • King's College London, Surrey, United Kingdom

  • Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland

  • Karolinska Institutet, Stockholm, Sweden

  • Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria

  • University of Glasgow, Glasgow, United Kingdom

  • Hospital Universitario La Paz, Madrid, Spain

  • University of Manchester, Manchester, United Kingdom

  • Brigham and Women's Hospital, Brookline, MA

  • The University of Manchester, Oberhaching, Germany

  • Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, Leiden, Netherlands

Locations

  • Philippines

  • Netherlands

  • Spain

  • Sweden

  • United Kingdom

  • Austria

  • United States

  • Germany

  • Switzerland

Companies

  • PharmAbcine Inc.

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Cluster of Differentiation 4

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A